Vipul Ambani, a runner who participated in city marathons, never wore his last name on his sleeve, was easy-going, mild-mannered and always smiling. Yet, the question that begs to be asked is why would he join a luxury jewellery company, says Pavan Lall.
Maserati, whose logo is modelled on the trident in the statue of Neptune in Bologna's Piazza Maggiore, was acquired by the Fiat Group in 2005.
Building a global brand was Choksi's idea, which Modi borrowed from him.
No one knows where billionaire Nirav Modi emerged from. What is known is that when he came (back) to India, he cut his teeth in the diamond business under the tutelage of his jeweller uncle. Then he began to build a glittering international brand. Soon even Hollywood stars like Kate Winslet and Dakota Johnson were walking the red carpet showing off Nirav Modi jewels.
Modi has been relentless in building his brand regardless of banks having a problem of fraudulent and unauthorised transactions with his companies.
The amount millenials spend on eating out is changing everything about the eating-out business.
Street may be ignoring TCS headwinds as the stock's peak valuation doesn't seem justified by BFSI weakness, likely higher US tax rates and stronger rupee, reports Ram Prasad Sahu.
In the quarter ended September 30, the Pirojsha Godrej-led firm recorded Rs 492 crore net sales, up 49% year-on-year
What stocks will gain from a normal monsoon?
Falling revenues, increased capex, and first full year of spectrum debt may make things worse
Revenues of Airtel and Idea have been hit by falling realisation and analysts said margins would be affected by higher costs.
Ambani said, in the telecom space, the focus will be on debt reduction, and the virtual merger did away with the need for major capex and will help towards this
Almost a third of the company's capex was stuck in this project
Godrej Properties, is on the horizon as it unlocks value in its high-value Bandra-Kurla Complex (BKC) project.
Given its network and fleet, it has garnered the highest share of passenger growth.
The reason is believed to be a 19% increase in interest cost.
Brokerages have cut the company's FY16 earnings estimates between 16% and 29% with target prices too coming down to the Rs 700-800 band
FIIs are looking at the long-term story and initiatives of Indian pharma companies to transform themselves into global entities.
Telcos have indicated that rates will have to be raised, as higher volumes alone will not suffice to meet the higher costs.
The challenge of merging Ranbaxy into the company has not been factored in.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances